ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer

被引：0
作者：
A. Koumarianou
P. Makrantonakis
F. Zagouri
C. Papadimitriou
A. Christopoulou
E. Samantas
C. Christodoulou
A. Psyrri
D. Bafaloukos
G. Aravantinos
P. Papakotoulas
S. Baka
C. Andreadis
A. Alexopoulos
I. Bompolaki
Κ. Kampoli
S. Liori
K. Karvounis
A. Ardavanis
机构：
[1] National and Kapodistrian University of Athens,Hematology Oncology Unit, Fourth Department of Internal Medicine, ATTIKON University General Hospital
[2] Medical School,Second Chemotherapeutic Clinic
[3] THEAGENIO Anti-Cancer Hospital of Thessaloniki,Therapeutic Clinic, ALEXANDRA General Hospital, Faculty of Medicine
[4] National and Kapodistrian University of Athens,Oncology Unit, 2nd Dept. of Surgery, ARETAIEIO University Hospital
[5] National and Kapodistrian University of Athens,Oncology Department
[6] AGIOS ANDREAS General Hospital of Patras,Third Oncology Clinic
[7] AGIOI ANARGIROI Athens General Hospital,Second Oncology Clinic
[8] METROPOLITAN Athens Private Hospital,Division Medical Oncology
[9] ATTIKON University General Hospital of Athens,First Oncology Clinic
[10] METROPOLITAN Athens Private Hospital,Second Oncology Clinic
[11] AGIOI ANARGIROI Athens General Hospital,First Chemotherapeutic Oncology Department
[12] THEAGENION Anti-Cancer Hospital of Thessaloniki,Oncology Department
[13] European INTERBALKAN Private Hospital of Thessaloniki,Third Department of Clinical Oncology and Chemotherapy
[14] THEAGENION Anti-Cancer Hospital of Thessaloniki,Oncology Department
[15] HYGEIA Athens Private Hospital,Oncology Department
[16] AGIOS GEORGIOS General Hospital of Chania,First Department of Medical Oncology
[17] AGIOS SAVVAS Athens General Hospital,Medical Department Hematology/Oncology
[18] Genesis Pharma S.A,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 182卷
关键词：
Metastatic breast cancer; -paclitaxel; Elderly; Second and later lines; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 96
页数：11
相关论文
共 57 条
  • [1] Ferlay J(2018)Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018 Eur J Cancer 103 356-387
  • [2] Colombet M(2012)Locally recurrent or metastatic breast cancer: esmo clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 23 11-19
  • [3] Soerjomataram I(2018)4th eso-esmo international consensus guidelines for advanced breast cancer (abc 4) Ann Oncol 29 1634-1657
  • [4] Cardoso F(2012)Taxanes for the treatment of metastatic breast cancer Breast Cancer (Auckl) 6 159-171
  • [5] Harbeck N(2005)Phase iii trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J Clin Oncol 23 7794-7803
  • [6] Fallowfield L(2015)Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in her2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life Drug Des Devel Ther 9 2189-2199
  • [7] Cardoso F(1997)Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument J Clin Oncol 15 974-986
  • [8] Senkus E(2018)Final effectiveness and safety results of nabucco: Real-world data from a noninterventional, prospective, multicenter study in 697 patients with metastatic breast cancer treated with nab-paclitaxel Clin Breast Cancer 18 e1323-e1337
  • [9] Costa A(2016)Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study Ann Oncol 27 74-6183
  • [10] Gradishar WJ(2015)Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients Drug Des Devel Ther 9 6177-493
123456